The Increasing Incidence of Geriatric Population in the World Is Augmenting the Growth of the Global Bone and Joint Health Ingredients Market

Bone and Joint Health Ingredients Market
Bone and Joint Health Ingredients Market

Bone and Joint Health Ingredients Market, By Type (Vitamin D, Vitamin K, Calcium, Collagen, Magnesium, Glucosamine, Omega-3, Other Types), By Application (Dietary Supplement, Functional Food, and Beverage), By Region (North America, Latin America, Europe, Asia Pacific, and Middle East & Africa) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030.

Market Overview:

Bone and joint health ingredients are substances or compounds that are specifically formulated to promote and support the health and well-being of bones and joints. These ingredients are commonly used in the development of dietary supplements, functional foods, and beverages targeted at improving bone density, preventing bone-related disorders, and enhancing joint mobility.

Competitive Landscape:

Major players operating in the global Bone and Joint Health Ingredients Market include Nature’s Sunshine Products, Inc., Arazo Nutrition, Vita Life Sciences Ltd., Pfizer, Reckitt Benckiser, Archer Daniels Midland, BASF SE, Amway, Procter & Gamble, and Bayer AG.

Key Market Drivers:

The global aging population is expected to augment the growth of the global bone and joint health ingredients for market. As individuals age, the risk of bone and joint-related ailments increases, leading to a higher demand for products that promote bone and joint health.

The prevalence of bone and joint disorders, such as osteoporosis and arthritis, has been rising globally. This has created a significant demand for bone and joint health ingredients, as these ingredients help prevent and manage these disorders.

The Bone and Joint Health Ingredients Market is anticipated to reach US$ 2,957.78 million in 2021 and grow at a CAGR of 6.34% from 2022 to 2030.

Consumers are becoming more conscious of their bone and joint health, leading to an increased demand for products that support bone and joint health. This growing awareness has driven manufacturers to develop innovative products with bone and joint health ingredients. This is estimated to enhance the growth of the global Bone and Joint Health Ingredients Market. For instance, in November 2021, Nature's Bounty introduced vitamin-infused jelly beans in order to cater to several wellness needs.

Advances in technology have resulted in the development of novel ingredients and formulations for bone and joint health. These advancements have improved the efficacy and bioavailability of bone and joint health ingredients, further driving the market growth.

Covid-19 Impact Analysis:

The COVID-19 pandemic caused disruptions in global supply chains, affecting the availability of raw materials and ingredients for bone and joint health products. This led to temporary supply shortages and price fluctuations in the global Bone and Joint Health Ingredients Market.

However, the pandemic has heightened the focus on health and wellness, leading to a surge in demand for products that support overall immune health, including bone and joint health. This increased demand has positively impacted the global bone and joint health ingredients for market. For instance, in December 2021, Flavor Infusion International(FISA) was acquired by ADM.

Key Takeaways:

· North America is expected to dominate the growth of the global bone and joint health ingredients for market, owing to the high prevalence of bone and joint disorders and the increasing aging population, along with product launches by key players. For instance, in February 2022, Amway introduced jelly strips, under the company's flagship brand, called Nutrilite.

· Europe is estimated to witness high growth in the global Bone and Joint Health Ingredients Market. Factors such as the rising awareness about bone health, government initiatives to promote healthy aging, and the presence of key market players have contributed to the growth in this region. For instance, in November 2020, the majority stake of Care/of was acquired by Bayers, the former is the manufacturer of high-quality health supplements.

Comments

Post a Comment

Popular posts from this blog

Sarcopenia Treatment; Training and Physical Exercise Is Key to Counteract Sarcopenia

Image
Sarcopenia Treatment A primary Sarcopenia Treatment is exercise. Researchers have identified resistance training as the specific form of exercise that is most beneficial to individuals with sarcopenia. At present, resistance exercise, protein supplementation, and vitamin D have been established as the basic treatment of sarcopenia. Recent clinical trials on sarcopenia therapies such as physical exercise, nutraceutical, and pharmaceutical interventions have revealed that exercise is the only effective strategy shown to alleviate sarcopenia. Sarcopenia refers to a loss of muscle mass specifically related to aging. It's normal to lose some muscle mass as people age. Sarcopenia has been defined as an age-related, involuntary loss of skeletal muscle mass and strength. Although aging is the main cause of sarcopenia, some other factors contribute to the loss of muscle mass. Getting little or no physical activity on a regular basis puts people at an increased risk of developing sarcopenia
Read more

Bioresorbable Implants Can Also Help To Prevent Complications And Speed Up The Recovery Process

Image
Bioresorbable Implants Medical implants, either passive for structural support or for diagnosis and therapy with active electronics, are widely used in surgical applications. Although they have shown long-term biocompatibility, their removal imposes physical, biological and economical burdens on patients. To overcome this drawback, implantable devices exhibiting biodegradation in the body have been developed. These implants disappear inside the body after a certain time of use, and can be replaced with natural bone. The resorption of Bioresorbable Implants is driven by hydrolysis of the bonds linking their monomers. The amorphous portions of the polymer degrade first, while the crystalline regions remain intact and provide most of their mechanical strength. The monomers are then broken down into lactic and glycolic acids, which are converted to pyruvate and then processed through the citric acid cycle into water and carbon dioxide. The Bioresorbable Implants Market was valued at US$
Read more

Increasing Developments by Key Players Are Expected To Augment the Growth of the Global Digital Pathology Market

Image
 Digital Pathology Digital Pathology Market , by Product Type (Image Analysis Software, Scanner {Bright Field Scanner, Fluorescence Scanner}, Services {Installation & Integration, Maintenance Services, Consulting Services}), by Therapeutic Area (Oncology, Hematology, Autoimmune Disorder, Dermatology, and Others), by Technology (Immunohistochemistry, ISH & FISH, Immunofluorescence and others) End User (Pharmaceutical & Biotechnology Companies, Diagnostic Labs, Hospital Laboratories, and Others), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)- Size, Share, Outlook, and Opportunity Analysis, 2023 - 2030. The global Digital Pathology Market is anticipated to reach an estimated value of US$ 884.4 million in 2023 and is projected to grow at a CAGR of 12.2% from 2023 to 2030. Market Overview: Digital pathology refers to the practice of digitizing glass slides containing tissue samples and analyzing them using digital imaging technology
Read more